Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × AC protocol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 1 Locally Advanced HER2-negative Breast Cancer 1 Hyperthermia 1

Interventions

Diathermy 18 Radiotherapy 10 Drug Therapy 5 Cisplatin 5 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Doxorubicin 2 Conization 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Therapeutics 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05889390 2024-12-03

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡